大麻使用对表现和治疗响应在性食道炎的影响
Stephanie A Borinsky1, Alexandra A Weir2, Sean S LaFata2
1Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
概括
大麻使用在埃索诺菲尔性食道炎 (EoE) 患者中显示出较温和的初始内镜检测结果,但治疗后炎症增加. 这表明大麻可能会对EoE管理和治疗结果产生负面影响.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于医疗和娱乐原因,大麻的使用正在增加.
- 关于大麻在性食道炎 (EoE) 的使用数据是有限的.
- 了解大麻对EoE的影响对于患者护理至关重要.
研究的目的:
- 为了研究大麻使用如何影响表现和治疗反应在异性食道炎 (EOE).
- 将大麻使用者和非使用者之间的基线特征和治疗结果与EoE进行比较.
主要方法:
- 对983名新诊断的EoE患者 (年龄≥12岁) 的回顾性队列研究.
- 分析自我报告的大麻使用情况,基线数据,以及对局部皮质类固醇和饮食治疗的反应.
- 两变量和多变量分析来比较大麻使用者和非使用者.
主要成果:
- 大麻使用者 (80/983) 的基线内镜检测结果 (排泄物,,狭窄,ERS) 较不严重,但症状和色素细胞计数的峰值相似.
- 大麻使用与年龄较小,男性性别,非白人种族和精神病诊断有关.
- 在治疗后,大麻使用者表现出类似的症状和组织学反应,但持续内镜炎症的几率更高.
结论:
- 患有EoE的大麻使用者呈现出较不严重的初始内镜特征.
- 尽管治疗反应相似,但大麻使用与治疗后内镜炎症增加有关.
- 大麻可能会对性食道炎的管理和结果产生负面影响.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
117
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
117
Gastroesophageal Reflux Disease II: Clinical Features and Management
57
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
57
Drugs Used in Lower Respiratory Disorders: Overview
358
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
358
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
203
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
203
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
241
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
226
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
226


